date:Jan 17, 2013
Biotechnology company Neptune Technologies Bioressources reports that it has increased nutraceutical revenues by 50% to $20,598,000 for the nine-month period ended November 30, with adjusted EBITDA decreasing by 11% to $2,225,000. The net loss from its nutraceutical business reached $13,632,000 for the nine-month period ended November 30, 2012, compared to a net profit of $1,004,000 for the corresponding period ended November 30, 2011.
Neptune said that the nutraceutical loss is mainly attribu